MATLAB is a leading environment for numerical computing, algorithm design, and data analysis used by engineers, researchers, ...

Syracuse, N.Y. ― A man on trial for murder took the stand Wednesday to testify that he stabbed his boyfriend in self-defense. Over two hours of testimony, Tyler Kilmer changed his version of what ...

I remember the feeling of getting a copy of PC Gamer from the grocery store because the demo CD inside had a game you wanted to try. The practice of demos started to fade out, and they would turn into ...

FONDA — The Root man indicted on six counts for allegedly abducting and assaulting a woman in January is apparently heading to trial next month. Charles Gray, 49, appeared briefly in Montgomery County ...

UTICA, N.Y. — Closing arguments were given Wednesday in the trial of three former prison guards charged with second-degree murder in the death of Robert Brooks. It took attorneys six days to rest ...

If you’ve yet to try the demo for Lumines Arise, now is the perfect time to get on that before the music game’s Nov. 11 release date. The PSP-era revival puts a hypnotic spin on the cult puzzle ...

As marketing bonanzas go, Steam Next Fest has a special place in my heart. A fancy trailer is nice and all, but these are videogames we're talking about—let me play them! I've already dipped my toe ...

Search freely within an ancient castle across a 3D map Apply reason and analyze the possibilities using keywords found in word clouds Join an auction where the truth is revealed about the past West ...

CervoMed Inc. (NASDAQ:CRVO) on Wednesday shared additional data from its Phase 2b RewinD-LB trial of neflamapimod for dementia with Lewy bodies (DLB). The results are based on the final analyses of ...

SALT LAKE CITY – Former Olympian and Berks County native Allison Baver has requested a new trial in her $10 million loan fraud case. In a court filing last month, Baver requested a new trial based on ...

Adicet Bio Inc. (NASDAQ:ACET) shares fell Tuesday after the biotechnology company priced an $80 million direct offering, even as early safety and efficacy data from its Phase 1 trial of ADI-001 in ...